SAN FRANCISCO and ATLANTA, Jan. 5, 2018 /PRNewswire/ -- Global Genomics Group ("G3"), a precision-medicine-based biopharmaceutical company that leverages large-scale genomic and molecular profiling to develop life-changing diagnostics and therapeutics, and Datavant, a healthcare...